Testing effectiveness (Phase 2)Study completedNCT00077441
What this trial is testing
Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 55